StockData
OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW

Oaktree Acquisition Corp. III Life Sciences

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.65−0.05 (-0.47%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

18 of Oaktree Acquisition Corp. III Life Sciences's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 16, 2026Oct 16, 2026SEC EDGAR
Current report8-KOct 14, 2026Oct 15, 2026SEC EDGAR
Proxy statementDEF 14AOct 16, 2026Oct 2, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 12, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 13, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 26, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 13, 2025SEC EDGAR
Current report8-KOct 29, 2025Oct 29, 2025SEC EDGAR
Current report8-KOct 17, 2025Oct 17, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 12, 2025SEC EDGAR
Current report8-KJun 3, 2025Jun 6, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 14, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 27, 2025SEC EDGAR
Current report8-KJan 6, 2025Jan 7, 2025SEC EDGAR
Current report8-KDec 11, 2024Dec 11, 2024SEC EDGAR
Current report8-KOct 30, 2024Nov 5, 2024SEC EDGAR
Current report8-KOct 25, 2024Oct 31, 2024SEC EDGAR
Current report8-KOct 23, 2024Oct 25, 2024SEC EDGAR